Bristol-Myers Squibb Net Change in Cash increased by 79.4% to $3.12B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 95.1%, from $1.60B to $3.12B. This is a positive signal — higher values indicate stronger performance for this metric.
An increase suggests the company is accumulating liquidity, while a decrease indicates it spent more on investments, debt repayment, or operations than it generated in cash.
This metric represents the total increase or decrease in a company's cash, cash equivalents, and restricted cash over a...
This is a universal accounting standard used to reconcile the cash flow statement to the balance sheet across all industries and global peers.
cf_net_change_in_cash| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $76.00M | $2.48B | -$1.74B | -$1.62B | -$3.00B | -$277.00M | -$623.00M | -$857.00M | $3.95B | -$2.19B | -$3.04B | $1.60B | $528.00M | $1.74B | $3.12B |
| QoQ Change | — | >999% | -170.0% | +6.8% | -85.5% | +90.8% | -124.9% | -37.6% | +561.0% | -155.3% | -39.0% | +152.6% | -66.9% | +228.8% | +79.4% |
| YoY Change | — | — | — | <-999% | -221.0% | +84.1% | +61.5% | +71.5% | — | -688.8% | -387.6% | +286.3% | +124.2% | +157.1% | +95.1% |
We use cookies for analytics. See our Privacy and Cookie Policy.